智通财经网·2025-11-27 13:01Core Viewpoint - 康希诺生物 has elected new independent non-executive directors during the extraordinary general meeting, indicating a shift in governance structure [2] Group 1: Board Elections - 左敏 and 纪雪峰 have been elected as independent non-executive directors of the third board [2] Group 2: Committee Adjustments - Following the extraordinary general meeting, the board has decided to adjust the composition of its committees, effective from November 27, 2025, until the term of the third board ends [2] - The Audit Committee will be chaired by 张耀樑, with members 纪雪峰 and 李志成 [2] - The Compensation and Assessment Committee will be chaired by 左敏, including members 张耀樑, 纪雪峰, 李志成, and 博士 Xuefeng YU [2] - The Nomination Committee will be chaired by 纪雪峰, with members 左敏 and 博士 Xuefeng YU [2]